Premium
[P4–458]: TARGETING THE APOLIPOPROTEIN E/AMYLOID β INTERACTION BY CPO_A β 17–21P, A NON‐TOXIC AND NON‐FIBRILLOGENIC PEPTOID, AMELIORATED A β ‐RELATED PATHOLOGY AND IMPROVED COGNITIVE DECLINE IN A MOUSE MODEL OF ALZHEIMER's DISEASE
Author(s) -
Liu Shan,
Allington Grant,
Prelli Frances,
Sun Yanjie,
MartaAriza Mitchell,
Mehta Pankaj D.,
Scholtzova Henrieta,
Brown Bernard,
Kwon YongUk,
Wisniewski Thomas
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.07.619
Subject(s) - apolipoprotein e , genetically modified mouse , chemistry , amyloid (mycology) , in vivo , pharmacology , cytotoxicity , cancer research , peptoid , in vitro , biochemistry , peptide , transgene , disease , medicine , biology , gene , genetics , inorganic chemistry